Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Spectrum Pharma Inc (SPPI)

Spectrum Pharma Inc (SPPI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 693,694
  • Shares Outstanding, K 145,734
  • Annual Sales, $ 0 K
  • Annual Income, $ -112,690 K
  • 60-Month Beta 2.29
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.37

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.37
  • Number of Estimates 3
  • High Estimate -0.30
  • Low Estimate -0.42
  • Prior Year -0.22
  • Growth Rate Est. (year over year) -68.18%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.65 +30.41%
on 08/25/20
5.11 -6.85%
on 09/18/20
+0.92 (+23.96%)
since 08/21/20
3-Month
2.91 +63.57%
on 08/03/20
5.11 -6.85%
on 09/18/20
+1.51 (+46.46%)
since 06/19/20
52-Week
1.74 +173.22%
on 03/19/20
10.57 -54.97%
on 12/11/19
-4.19 (-46.82%)
since 09/20/19

Most Recent Stories

More News
Spectrum Pharmaceuticals (SPPI) Jumps: Stock Rises 7%

Spectrum Pharmaceuticals (SPPI) saw a big move last session, as its shares jumped 7% on the day, amid huge volumes.

SPPI : 4.76 (-2.86%)
CTLT : 85.55 (+0.80%)
Spectrum Pharmaceuticals Presents Results in HER2 Exon 20 Insertion Mutations from Cohort 2 of the Poziotinib ZENITH20 Clinical Trial

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today presented additional results from its pivotal Phase 2 clinical trial, ZENITH20,...

SPPI : 4.76 (-2.86%)
Implied Volatility Surging for Spectrum (SPPI) Stock Options

Investors need to pay close attention to Spectrum (SPPI) stock based on the movements in the options market lately.

SPPI : 4.76 (-2.86%)
Spectrum Pharmaceuticals Announces Two Presentations for Poziotinib at ESMO Virtual Congress 2020

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced a presentation of the results for Cohort 2 from its Phase 2 clinical...

SPPI : 4.76 (-2.86%)
Spectrum Pharmaceuticals to Present at Two Upcoming Investor Conferences in September

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, announced today that management will present an overview of the company's business...

SPPI : 4.76 (-2.86%)
Spectrum Pharmaceuticals (SPPI) Reports Q2 Loss, Lags Revenue Estimates

Spectrum Pharma (SPPI) delivered earnings and revenue surprises of 12.12% and -100.00%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

SPPI : 4.76 (-2.86%)
Spectrum Pharma: 2Q Earnings Snapshot

HENDERSON, Nev. (AP) _ Spectrum Pharmaceuticals Inc. (SPPI) on Monday reported a loss of $32.1 million in its second quarter.

SPPI : 4.76 (-2.86%)
Spectrum Pharmaceuticals Reports Second Quarter 2020 Financial Results and Corporate Update

--Company is in process of requesting a pre-NDA meeting with the FDA seeking an indication for second-line NSCLC patients with HER2 exon 20 insertion mutations

SPPI : 4.76 (-2.86%)
Spectrum Pharmaceuticals Announces Full Exercise of Underwriters' Option to Purchase Additional Shares

Spectrum Pharmaceuticals, Inc. (Nasdaq: SPPI) ("Spectrum" or the "Company"), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that the underwriters of its previously...

SPPI : 4.76 (-2.86%)
Spectrum Pharmaceuticals to Report Second Quarter 2020 Financial Results and Provide Corporate Update

Spectrum Pharmaceuticals (NasdaqGS: SPPI) a biopharmaceutical company focused on novel and targeted oncology therapies, today announced it will host a conference call to discuss the second quarter 2020...

SPPI : 4.76 (-2.86%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade SPPI with:

Business Summary

Spectrum Pharmaceuticals, Inc. is opportunistically acquiring and advancing a diversified portfolio of oncology drug candidates that meet critical health challenges for which there are few other treatment options. Spectrum's expertise lies in identifying undervalued drugs with demonstrated safety and...

See More

Key Turning Points

2nd Resistance Point 5.05
1st Resistance Point 4.90
Last Price 4.76
1st Support Level 4.56
2nd Support Level 4.37

See More

52-Week High 10.57
Fibonacci 61.8% 7.20
Fibonacci 50% 6.16
Fibonacci 38.2% 5.11
Last Price 4.76
52-Week Low 1.74

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar